Several companies have announced a range of financial activities, including proposed public offerings of common stock and pre-funded warrants. Additionally, some firms declared quarterly dividends and released previews or results for their first-quarter earnings.

Spruce Biosciences (SPRB) has appointed Dale Hooks as its Chief Commercial Officer and reported a narrowed net loss of $39 million for 2025.

Dianthus Therapeutics reported a GAAP EPS of -$1.43, missing estimates by $0.34, and revenue of $0.28M, missing by $0.17M.